analysis of aurobindo pharma for intraday on 02 feb 2022.
on daily timeframe it is making double bottom
and lower timeframe it has broken its downward trendline
we are expecting a long view on breakout of reisitance
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.